Dapagliflozin in heart failure: new frontiers

被引：5
|
作者：
Tromp, Jasper [1 ,2 ,3 ]
Collins, Sean P. [4 ]
机构：
[1] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
[2] Duke NUS Med Sch, Dept Cardiol, Singapore, Singapore
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷 / 11期
关键词：
D O I：
10.1002/ejhf.1633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article refers to 'The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics', by J.J.V. McMurray et al., published in this issue on pages 1402-1411.
引用
收藏
页码：1412 / 1414
页数：3
相关论文
共 50 条
  • [41] EFFICACY AND SAFTY OF DAPAGLIFLOZIN FOR HEART FAILURE: A SYSTEMIC REVIEW
    Wang, Zhe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [42] Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction
    Lu, Ying
    Li, Yongnan
    Xie, Yixin
    Bu, Jiale
    Yuan, Ruowen
    Zhang, Xiaowei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [43] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
    Petrie, Mark C.
    Verma, Subodh
    Docherty, Kieran F.
    Inzucchi, Silvio E.
    Anand, Inder
    Belohlavek, Jan
    Boehm, Michael
    Chiang, Chern-En
    Chopra, Vijay K.
    de Boer, Rudolf A.
    Desai, Akshay S.
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andre
    Ge, Junbo
    Howlett, Jonathan
    Katova, Tzvetana
    Kitakaze, Masafumi
    Ljungman, Charlotta E. A.
    Merkely, Bela
    Nicolau, Jose C.
    O'Meara, Eileen
    Vinh, Pham Nguyen
    Schou, Morten
    Tereshchenko, Sergey
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Johanson, Per
    Greasley, Peter J.
    Boulton, David
    Bengtsson, Olof
    Jhund, Pardeep S.
    McMurray, John J. V.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1353 - 1368
  • [44] Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
    Butt, Jawad H.
    Docherty, Kieran F.
    Petrie, Mark C.
    Schou, Morten
    Kosiborod, Mikhail N.
    O'Meara, Eileen
    Katova, Tzvetana
    Ljungman, Charlotta E. A.
    Diez, Mirta
    Ogunniyi, Modele O.
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Lindholm, Daniel
    Bengtsson, Olof
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Kober, Lars
    JAMA CARDIOLOGY, 2021, 6 (06) : 678 - 689
  • [45] Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
    McMurray, John J., V
    Wheeler, David C.
    Stefansson, Bergur, V
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Hou, Fan Fan
    Rossing, Peter
    Sjostrom, C. David
    Solomon, Scott D.
    Toto, Robert D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    JACC-HEART FAILURE, 2021, 9 (11) : 807 - 820
  • [46] Topping Off the Pill Box Dapagliflozin, Heart Failure, and Polypharmacy
    Park, Jin Joo
    Greenberg, Barry
    JACC-HEART FAILURE, 2023, 11 (10) : 1394 - 1396
  • [47] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J., V
    Claggett, B.
    de Boer, R. A.
    DeMets, D.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F.
    Shah, S. J.
    Desai, A. S.
    Jhund, P. S.
    Belohlavek, J.
    Chiang, C-E
    Borleffs, C. J. W.
    Comin-Colet, J.
    Dobreanu, D.
    Drozdz, J.
    Fang, J. C.
    Alcocer-Gamba, M. A.
    Al Habeeb, W.
    Han, Y.
    Cabrera Honorio, J. W.
    Janssens, S. P.
    Katova, T.
    Kitakaze, M.
    Merkely, B.
    O'Meara, E.
    Saraiva, J. F. K.
    Tereshchenko, S. N.
    Thierer, J.
    Vaduganathan, M.
    Vardeny, O.
    Verma, S.
    Pham, V. N.
    Wilderang, U.
    Zaozerska, N.
    Bachus, E.
    Lindholm, D.
    Petersson, M.
    Langkilde, A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, : 1089 - 1098
  • [48] Exploring new frontiers: CA-125 and emerging biomarkers in heart failure research
    Sammartano, A.
    Spaggiari, P.
    Ferretti, S.
    Amadei, M.
    Testa, G.
    Tortorella, G.
    Ippolito, L.
    CLINICA CHIMICA ACTA, 2024, 558
  • [49] Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure
    Kurdi, H. Hibba
    Shah, P.
    Barker, S.
    Dicken, B.
    Edwards, C.
    Jenkins, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 15 - 16
  • [50] Dapagliflozin reduces Atrial Fibrillation in Diabetic Patients with Heart Failure
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2020, 9 (04) : 338 - 338
12345